🇺🇸 vitamin B6 (pyridoxine) in United States
115 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 115
Most-reported reactions
- Fatigue — 18 reports (15.65%)
- Diarrhoea — 17 reports (14.78%)
- Pneumonia — 16 reports (13.91%)
- White Blood Cell Count Decreased — 13 reports (11.3%)
- Headache — 11 reports (9.57%)
- Deep Vein Thrombosis — 9 reports (7.83%)
- Platelet Count Decreased — 9 reports (7.83%)
- Dyspnoea — 8 reports (6.96%)
- Asthenia — 7 reports (6.09%)
- Neutrophil Count Decreased — 7 reports (6.09%)
Other Nutritional/Metabolic approved in United States
Frequently asked questions
Is vitamin B6 (pyridoxine) approved in United States?
vitamin B6 (pyridoxine) does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for vitamin B6 (pyridoxine) in United States?
Haukeland University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.